Kevin C. Barry

A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments

Kevin C. Barry, Joy Hsu, Miranda L. Broz et al. · Nature Medicine · 2018 · 973 citations

Tumor Biology, Natural Killer–dendritic Cell, Tumor Immunology +14

Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity

Mikhail Binnewies, Adriana M. Mujal, Joshua L. Pollack et al. · Cell · 2019 · 596 citations · Full text

Cancer Immunosurveillance, Type-2 Dendritic Cells, Autoimmune Disease +8

Secreted Bacterial Effectors That Inhibit Host Protein Synthesis Are Critical for Induction of the Innate Immune Response to Virulent Legionella pneumophila

Mary F. Fontana, Simran Banga, Kevin C. Barry et al. · PLoS Pathogens · 2011 · 227 citations · Full text

Microbial Pathogens, Tlr Ligands, Innate Immune System +22

Discovering dominant tumor immune archetypes in a pan-cancer census

Alexis J. Combes, Bushra Samad, Jessica Tsui et al. · Cell · 2021 · 162 citations · Full text

Tumor Biology, Cancer Immunosurveillance, Tumor Heterogeneity +8

IL-1α Signaling Initiates the Inflammatory Response to Virulent <i>Legionella pneumophila</i> In Vivo

Kevin C. Barry, Mary F. Fontana, Jonathan L. Portman et al. · The Journal of Immunology · 2013 · 133 citations · Full text